Barreiro, A., Sisteré-Oró, M., Cebollada Rica, P., Meyerhans, A., & Ferrer, L. (2023). Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2.
Citación estilo ChicagoBarreiro, Antonio, Marta Sisteré-Oró, Paula Cebollada Rica, Andreas Meyerhans, y Laura Ferrer. Preclinical Evaluation of a COVID-19 Vaccine Candidate Based On a Recombinant RBD Fusion Heterodimer of SARS-CoV-2. 2023.
Cita MLABarreiro, Antonio, et al. Preclinical Evaluation of a COVID-19 Vaccine Candidate Based On a Recombinant RBD Fusion Heterodimer of SARS-CoV-2. 2023.
Precaución: Estas citas no son 100% exactas.